Manufacturing Quality and Safety Risks of Regenerative Medicine Products

The risk that contamination or mutations in the manufacturing process, lot-to-lot quality differences, new safety findings, or adverse event reports involving regenerative medicine products such as exosomes and cell-based products could lead to recalls, suspension of sales, or a loss of confidence.